Articles related to ‘FDA media releases’
-
Golimumab (Simponi) side effects: risk of serious fungal infections
-
TNF blockers and lymphoma: FDA adds boxed warning
-
FDA video: interaction of IV ceftriaxone with calcium-containing products
-
FDA video on erlotinib (Tarceva) adverse effects
-
FDA approves bevacizumab (Avastin) for glioblastoma multiforme
-
FDA video warning on metoclopramide and tardive dyskinesia
-
FDA: potential risk of HIV and hepatitis transmission when insulin pens and cartridges are shared
-
Metoclopramide and tardive dyskinesia: FDA adds boxed warning
-
Zonisamide (Zonegran): FDA warns about risk of metabolic acidosis and issues recommendations
-
Efalizumab (Raptiva) for plaque psoriasis. EMEA recommends withdrawal of its marketing authorization, FDA issues public health advisory
-
FDA approves ATryn (recombinant human antithrombin) for the treatment of hereditary antithrombin deficiency
-
Xigris (Drotrecogin alfa activated): concerns of serious bleeding and increased death trigger FDA safety review
-
FDA recommendations on clopidogrel (Plavix) because of decreased response and PPI interactions
-
FDA updated information about a safety review of Ezetimibe/Simvastatin (Vytorin), Ezetimibe (Zetia), and Simvastatin (Zocor)
